QHRD-106 | Interleukin Related interleukin-related.com

Product Name :
QHRD-106

Search keywords :
BDKRB2

drugId :
null

Target Vo:
Bradykinin B2 receptor

Target Vo Short Name :
BKR2

Moa_Name:
Bradykinin B2 receptor antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Changzhou Qianhong Biopharma Co Ltd

Active Company_Name :
Changzhou Qianhong Biopharma Co Ltd

Active Indication_Name:
Stroke

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
beta Tubulin Rabbit mAb web
Bmi1 Mouse mAb medchemexpress
BRCA1 Antibody: BRCA1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 208 kDa, targeting to BRCA1. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Rat.

Author: Interleukin Related

Related Posts